Literature DB >> 33386415

Clinical outcomes after single-versus double-embryo transfers in women with adenomyosis: a retrospective study.

Jiayi Guo1, Zhi Zeng1, Manchao Li1, Jiana Huang1, Jintao Peng1, Meng Wang1, Xiaoyan Liang1, Haitao Zeng2.   

Abstract

BACKGROUND: Adenomyosis affects the outcomes of spontaneous fertility and assisted reproductive technology. The single blastocyst embryo transfer (SBT) policy is an effective strategy known to minimize the risk of multiple pregnancy for non-adenomyosis women. However, little is known about its applicability to women with adenomyosis. The purpose of this study is to compare pregnancy outcomes between SBT, double-blastocyst embryo transfer (DBT), single-cleavage-stage embryo transfer (SET) and double-cleavage-stage embryo transfer (DET) in the frozen-thawed embryo transfer cycles among adenomyosis patients.
METHODS: This retrospective study was conducted in all frozen-thawed autologous embryo transfer cycles. 393 frozen-thawed embryo transfer cycles performed in adenomyosis patients were enrolled. The major clinical outcomes were implantation rate (IR), clinical pregnancy rate (CPR), miscarriage rate (MR), multiple pregnancy rate (MPR) and live birth rate (LBR).
RESULTS: The SBT and DBT groups achieved higher IR (P < 0.001), CPR (P = 0.017), LBR (P = 0.040) and lower MR (P = 0.020) than the SET and DET groups. But the SBT and DBT groups achieved similar CPR and LBR. The SBT and SET groups achieved lower MPR (P < 0.001) than the DBT and DET groups. The average birth weight (BW) of SBT groups was higher than the DBT and DET groups (P = 0.016). When compared with SBT group, low-birth-weight infants were significantly higher with DBT and DET.
CONCLUSIONS: When performing frozen-thawed embryo transfer cycles among adenomyosis patients, the SBT group has similar IR, CPR, MR, LBR but lower MPR compared to the DBT group. Therefore, SBT might be offered as standard practice.

Entities:  

Keywords:  Adenomyosis; In vitro fertilization; Infertility; Neonatal outcomes; Pregnancy outcomes; Single-embryo transfers

Year:  2021        PMID: 33386415     DOI: 10.1007/s00404-020-05924-5

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  33 in total

Review 1.  Adenomyosis and subfertility: a systematic review of prevalence, diagnosis, treatment and fertility outcomes.

Authors:  Abha Maheshwari; Sumana Gurunath; Farah Fatima; Siladitya Bhattacharya
Journal:  Hum Reprod Update       Date:  2012-03-22       Impact factor: 15.610

2.  Estrogen and progesterone receptor isoform distribution through the menstrual cycle in uteri with and without adenomyosis.

Authors:  Mohamed Khairy Mehasseb; Rina Panchal; Anthony Henry Taylor; Laurence Brown; Stephen Charles Bell; Marwan Habiba
Journal:  Fertil Steril       Date:  2011-03-27       Impact factor: 7.329

3.  Immunohistochemical assessment of superoxide dismutase expression in the endometrium in endometriosis and adenomyosis.

Authors:  H Ota; S Igarashi; J Hatazawa; T Tanaka
Journal:  Fertil Steril       Date:  1999-07       Impact factor: 7.329

4.  Involvement of catalase in the endometrium of patients with endometriosis and adenomyosis.

Authors:  Hirotaka Ota; Shinichi Igarashi; Naoki Sato; Hidenori Tanaka; Toshinobu Tanaka
Journal:  Fertil Steril       Date:  2002-10       Impact factor: 7.329

5.  Relationship between the magnetic resonance imaging appearance of adenomyosis and endometriosis phenotypes.

Authors:  Charles Chapron; Claudia Tosti; Louis Marcellin; Mathilde Bourdon; Marie-Christine Lafay-Pillet; Anne-Elodie Millischer; Isabelle Streuli; Bruno Borghese; Felice Petraglia; Pietro Santulli
Journal:  Hum Reprod       Date:  2017-07-01       Impact factor: 6.918

6.  How common is adenomyosis? A prospective study of prevalence using transvaginal ultrasound in a gynaecology clinic.

Authors:  J Naftalin; W Hoo; K Pateman; D Mavrelos; T Holland; D Jurkovic
Journal:  Hum Reprod       Date:  2012-09-20       Impact factor: 6.918

7.  Leukemia inhibitory factor is dysregulated in the endometrium and uterine flushing fluid of patients with adenomyosis during implantation window.

Authors:  Yu Xiao; Xiao Sun; Xiuli Yang; Jun Zhang; Qing Xue; Bocen Cai; Yingfang Zhou
Journal:  Fertil Steril       Date:  2009-04-09       Impact factor: 7.329

8.  Prevalence of adenomyosis in women undergoing surgery for endometriosis.

Authors:  Nadine Di Donato; Giulia Montanari; Arianna Benfenati; Debora Leonardi; Valentina Bertoldo; Giorgia Monti; Diego Raimondo; Renato Seracchioli
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2014-08-15       Impact factor: 2.435

9.  Adenomyosis in infertile women: prevalence and the role of 3D ultrasound as a marker of severity of the disease.

Authors:  J M Puente; A Fabris; J Patel; A Patel; M Cerrillo; A Requena; J A Garcia-Velasco
Journal:  Reprod Biol Endocrinol       Date:  2016-09-20       Impact factor: 5.211

10.  Coronavirus disease 2019 in pregnant women: a report based on 116 cases.

Authors:  Jie Yan; Juanjuan Guo; Cuifang Fan; Juan Juan; Xuechen Yu; Jiafu Li; Ling Feng; Chunyan Li; Huijun Chen; Yuan Qiao; Di Lei; Chen Wang; Guoping Xiong; Fengyi Xiao; Wencong He; Qiumei Pang; Xiaoling Hu; Suqing Wang; Dunjin Chen; Yuanzhen Zhang; Liona C Poon; Huixia Yang
Journal:  Am J Obstet Gynecol       Date:  2020-04-23       Impact factor: 10.693

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.